Depomed Gets Favorable Nucynta Patent Decision
Depomed Inc. said it received a favorable court decision on its patents for its Nucynta painkiller products and expected the ruling would result in market exclusivity through 2025. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 30, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe
GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker ’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange Commission said Friday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 30, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
For Small-Town Cops, Opioid Scourge Hits Close to Home
A flood of fentanyl and heroin is straining local budgets, putting police at risk as drug networks spread. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 29, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA Approves Medtronic's New Automated Insulin Pump
The U.S. Food and Drug Administration said it has approved an insulin pump by medical device company Medtronic that automatically manages glucose levels within a target range. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 28, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results
Intra-Cellular Therapies said its lead drug candidate had a similar rate of effectiveness to placebo in a Phase 3 schizophrenia trial. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 28, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
